Prot # STEM-104-M-CHF: Phase IIa, Single blind, Placebo-Controlled, Crossover, Multi-Center, Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia Tolerant Allogeneic Mesenchymal Bone Marrow

  • Anderson, Allen Sawyer (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/10/14 → 7/10/17

Funding

  • CardioCell LLC (STEM-104-M-CHF)